BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15808547)

  • 1. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
    Siemionow MZ; Klimczak A; Unal S
    Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
    Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
    Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model.
    Klimczak A; Unal S; Jankowska A; Coburn C; Siemionow M
    Bone Marrow Transplant; 2007 Aug; 40(4):373-80. PubMed ID: 17572707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
    Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
    Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
    J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
    Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
    Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
    Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
    Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
    Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
    J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
    Ozer K; Izycki D; Zielinski M; Siemionow M
    Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraosseus transplantation of donor-derived hematopoietic stem and progenitor cells induces donor-specific chimerism and extends composite tissue allograft survival.
    Siemionow M; Zielinski M; Ozmen S; Izycki D
    Transplant Proc; 2005 Jun; 37(5):2303-8. PubMed ID: 15964405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor bone marrow in laryngeal transplantation: results of a rat study.
    Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
    Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.